AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35414532 — intervention group
Group type: COMPARATOR
Intervention: Baseline phase (no intervention).
Number of subjects: 6364
Study 35414532 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifaceted intervention bundle.
Number of subjects: 6364
Study 33769837 — intervention group
Group type: EXPERIMENTAL
Intervention: Community qigong classes
Number of subjects: 20
Study 33769837 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 20
Study 35639721 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrate/nitrite supplementation (beetroot juice containing 4.03 mmol nitrate, 0.29 mmol nitrite) for eight weeks
Number of subjects: 0
Study 35639721 — intervention group
Group type: COMPARATOR
Intervention: Placebo (nitrate/nitrite-depleted beetroot juice)
Number of subjects: 0
Study 34965947 — intervention group
Group type: EXPERIMENTAL
Intervention: Enzalutamide 160 mg/day
Number of subjects: 1199
Study 34965947 — intervention group
Group type: COMPARATOR
Intervention: Baseline corticosteroid use (CCU)
Number of subjects: 1199
Study 33637927 — intervention group
Group type: EXPERIMENTAL
Intervention: 24-month recall
Number of subjects: 2372
Study 33637927 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk-based recall
Number of subjects: 2372
Study 35451408 — intervention group
Group type: EXPERIMENTAL
Intervention: Yanghe decoction plus NAC
Number of subjects: 128
Study 35451408 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus NAC
Number of subjects: 128
Study 33819910 — intervention group
Group type: EXPERIMENTAL
Intervention: Identity-based PSA tailored for Christians
Number of subjects: 292
Study 33819910 — intervention group
Group type: EXPERIMENTAL
Intervention: Identity-based PSA focused on economic values
Number of subjects: 292
Study 33819910 — intervention group
Group type: COMPARATOR
Intervention: Control PSA providing only information
Number of subjects: 292
Study 33087330 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetuximab
Number of subjects: 242
Study 35309831 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive nursing (group B)
Number of subjects: 44
Study 35309831 — intervention group
Group type: COMPARATOR
Intervention: Healthy volunteers (control group)
Number of subjects: 44
Study 32598470 — intervention group
Group type: EXPERIMENTAL
Intervention: Generic antidepressants (sertraline, paroxetine, escitalopram, venlafaxine, mirtazapine, bupropion)
Number of subjects: 548234
Study 32598470 — intervention group
Group type: COMPARATOR
Intervention: Brand-name antidepressants
Number of subjects: 548234
Study 33992268 — intervention group
Group type: EXPERIMENTAL
Intervention: 50% dextrose phonophoresis for 5 min and therapeutic ultrasound for 5 min
Number of subjects: 45
Study 33992268 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsed Electromagnetic Field (PEMF) with frequency of 50 HZ for 50 min
Number of subjects: 45
Study 33992268 — intervention group
Group type: COMPARATOR
Intervention: Traditional physiotherapy ultrasound for 5 min
Number of subjects: 45
Study 32397966 — intervention group
Group type: EXPERIMENTAL
Intervention: Specialist LINK
Number of subjects: 251
Study 32397966 — intervention group
Group type: EXPERIMENTAL
Intervention: PCN Clinical Pathways
Number of subjects: 251
Study 35369705 — intervention group
Group type: EXPERIMENTAL
Intervention: Vupanorsen (60 mg every 2 weeks)
Number of subjects: 286
Study 35369705 — intervention group
Group type: EXPERIMENTAL
Intervention: Vupanorsen (80 mg every 2 weeks)
Number of subjects: 286
Study 35369705 — intervention group
Group type: EXPERIMENTAL
Intervention: Vupanorsen (various doses)
Number of subjects: 286
Study 35369705 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 286
Study 34218802 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxycycline-based quadruple regimen (bismuth subsalicylate 524 mg four times daily, doxycycline 100 mg, tinidazole 500 mg, and esomeprazole 20 mg, each twice per day for 2 weeks)
Number of subjects: 78
Study 34218802 — intervention group
Group type: COMPARATOR
Intervention: Levofloxacin concomitant regimen (levofloxacin 500 mg daily, tinidazole 500 mg, amoxicillin 1000 mg, and esomeprazole 20 mg each twice per day for two weeks)
Number of subjects: 78
Study 34602338 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal voice intervention (voice recordings of the mother reading a children's book played during heel stick procedure once daily for 3 consecutive days)
Number of subjects: 64
Study 34602338 — intervention group
Group type: COMPARATOR
Intervention: Control group (no maternal voice intervention)
Number of subjects: 64
Study 34320709 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy (ACTx)
Number of subjects: 45
Study 34320709 — intervention group
Group type: COMPARATOR
Intervention: Surgical treatment only (Control)
Number of subjects: 45
Study 37744073 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual care plus remotely delivered EMDR R-TEP
Number of subjects: 26
Study 37744073 — intervention group
Group type: COMPARATOR
Intervention: Usual care alone (controls)
Number of subjects: 26
Study 34236672 — intervention group
Group type: EXPERIMENTAL
Intervention: Peanut allergen powder‐dnfp (PTAH) oral immunotherapy
Number of subjects: 0
Study 34236672 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 35459665 — intervention group
Group type: EXPERIMENTAL
Intervention: Home energy intervention (Victorian Healthy Homes Program)
Number of subjects: 1000
Study 35459665 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention before winter)
Number of subjects: 1000
Study 32723193 — intervention group
Group type: EXPERIMENTAL
Intervention: 350 mg dose of herbal supplement (70:30 blend of Rhaponticum carthamoides extract and Rhodiola rosea extract)
Number of subjects: 30
Study 32723193 — intervention group
Group type: EXPERIMENTAL
Intervention: 175 mg dose of herbal supplement plus 175 mg of maltodextrin
Number of subjects: 30
Study 32723193 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 32723193 — intervention group
Group type: EXPERIMENTAL
Intervention: All interventions (herbal supplement and placebo)
Number of subjects: 30
Study 36129733 — intervention group
Group type: EXPERIMENTAL
Intervention: Endocare (virtual reality digital treatment)
Number of subjects: 45
Study 36129733 — intervention group
Group type: COMPARATOR
Intervention: 2D digital control
Number of subjects: 45
Study 33821898 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity walking exercise (n=116)
Number of subjects: 305
Study 33821898 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity walking exercise (n=124)
Number of subjects: 305
Study 33821898 — intervention group
Group type: COMPARATOR
Intervention: Nonexercise control (n=65)
Number of subjects: 305
Study 33821898 — intervention group
Group type: EXPERIMENTAL
Intervention: Between-group comparison (low-intensity vs high-intensity)
Number of subjects: 305
Study 33821898 — intervention group
Group type: EXPERIMENTAL
Intervention: Between-group comparison (low-intensity vs nonexercise control)
Number of subjects: 305
Study 35810744 — intervention group
Group type: EXPERIMENTAL
Intervention: Bronchoscopic instillation of voriconazole
Number of subjects: 60
Study 35810744 — intervention group
Group type: COMPARATOR
Intervention: Medical therapy (MT) alone
Number of subjects: 60
Study 33538091 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive systolic blood pressure control (target <120 mm Hg)
Number of subjects: 9210
Study 33538091 — intervention group
Group type: COMPARATOR
Intervention: Standard systolic blood pressure control (target <140 mm Hg)
Number of subjects: 9210
Study 33538091 — intervention group
Group type: EXPERIMENTAL
Intervention: Each 5 kg/m2 increase in baseline BMI
Number of subjects: 9210
Study 34623507 — intervention group
Group type: EXPERIMENTAL
Intervention: Local application of hyaluronic acid (HA) on both donor and recipient sites
Number of subjects: 24
Study 34623507 — intervention group
Group type: COMPARATOR
Intervention: Normal saline application (Control)
Number of subjects: 24
Study 34623507 — intervention group
Group type: EXPERIMENTAL
Intervention: Local application of hyaluronic acid (HA)
Number of subjects: 24
Study 34339370 — intervention group
Group type: EXPERIMENTAL
Intervention: STRAP (Style Transfer Augmentation)
Number of subjects: 0
Study 36456021 — intervention group
Group type: EXPERIMENTAL
Intervention: Inulin (20 g/day of powdered supplement dissolved in water)
Number of subjects: 0
Study 36456021 — intervention group
Group type: COMPARATOR
Intervention: Maltodextrin (placebo control)
Number of subjects: 0
Study 36456021 — intervention group
Group type: EXPERIMENTAL
Intervention: Inulin
Number of subjects: 0
Study 32316168 — intervention group
Group type: EXPERIMENTAL
Intervention: Altitude training camp for 11 days
Number of subjects: 20
Study 32316168 — intervention group
Group type: COMPARATOR
Intervention: Control group (no altitude training)
Number of subjects: 20
Study 34807243 — intervention group
Group type: EXPERIMENTAL
Intervention: Aducanumab (10 mg/kg)
Number of subjects: 3285
Study 34807243 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3285
Study 35352383 — intervention group
Group type: EXPERIMENTAL
Intervention: Swallowing training combined with nutritional intervention
Number of subjects: 66
Study 35352383 — intervention group
Group type: COMPARATOR
Intervention: Routine health counseling and swallowing training
Number of subjects: 66
Study 33307932 — intervention group
Group type: EXPERIMENTAL
Intervention: Adapted consent form using Fuzzy Trace Theory
Number of subjects: 86
Study 33307932 — intervention group
Group type: COMPARATOR
Intervention: Standard consent form
Number of subjects: 86
Study 34743011 — intervention group
Group type: EXPERIMENTAL
Intervention: Natural Language Processing (NLP) for identifying uncontrolled symptoms
Number of subjects: 296
Study 33054727 — intervention group
Group type: EXPERIMENTAL
Intervention: Early ultrafiltration
Number of subjects: 100
Study 33054727 — intervention group
Group type: COMPARATOR
Intervention: Torasemide plus tolvaptan
Number of subjects: 100
Study 33548747 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic Touch (TT)
Number of subjects: 96
Study 33548747 — intervention group
Group type: COMPARATOR
Intervention: Sham Therapeutic Touch (STT)
Number of subjects: 96
Study 33548747 — intervention group
Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 96
Study 35123566 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally adapted brief negotiational intervention (PPKAY) with standard SMS booster
Number of subjects: 0
Study 35123566 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally adapted brief negotiational intervention (PPKAY) with personalized SMS booster
Number of subjects: 0
Study 35123566 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally adapted brief negotiational intervention (PPKAY) without SMS booster
Number of subjects: 0
Study 35123566 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 0
Study 35123566 — intervention group
Group type: EXPERIMENTAL
Intervention: PPKAY with standard SMS booster
Number of subjects: 0
Study 35123566 — intervention group
Group type: EXPERIMENTAL
Intervention: PPKAY with personalized SMS booster
Number of subjects: 0
Study 32796410 — intervention group
Group type: EXPERIMENTAL
Intervention: Kyphosis exercise and posture training intervention (twice weekly for 3 months)
Number of subjects: 103
Study 32796410 — intervention group
Group type: EXPERIMENTAL
Intervention: Kyphosis exercise and posture training intervention
Number of subjects: 103
Study 35447622 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrice-weekly moderate-intensity aerobic-based exercise over 24 weeks (including 8 weeks of supervised in-center and home-based sessions followed by 16 weeks of home-based sessions)
Number of subjects: 44
Study 35447622 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrice-weekly moderate-intensity aerobic-based exercise
Number of subjects: 44
Study 35447622 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 44
Study 34555409 — intervention group
Group type: EXPERIMENTAL
Intervention: MAST (n = 23)
Number of subjects: 45
Study 34555409 — intervention group
Group type: COMPARATOR
Intervention: MAST-placebo (n = 22)
Number of subjects: 45
Study 34555409 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (MAST and MAST-placebo)
Number of subjects: 45
Study 35339397 — intervention group
Group type: EXPERIMENTAL
Intervention: Homeopathic medicine Natrum muriaticum LM2
Number of subjects: 86
Study 35339397 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 86
Study 34217657 — intervention group
Group type: EXPERIMENTAL
Intervention: Right Ventricular (RV) pacing
Number of subjects: 30
Study 34217657 — intervention group
Group type: COMPARATOR
Intervention: Biventricular (BiV) pacing
Number of subjects: 30
Study 32705417 — intervention group
Group type: EXPERIMENTAL
Intervention: Rocuronium 1 mg/kg
Number of subjects: 40
Study 32705417 — intervention group
Group type: COMPARATOR
Intervention: Rocuronium 0.6 mg/kg
Number of subjects: 40
Study 36045877 — intervention group
Group type: EXPERIMENTAL
Intervention: IM progesterone in oil (25 mg daily)
Number of subjects: 312
Study 36045877 — intervention group
Group type: EXPERIMENTAL
Intervention: IM progesterone in oil (50 mg daily)
Number of subjects: 312
Study 36045877 — intervention group
Group type: EXPERIMENTAL
Intervention: Progesterone suppository (400 mg daily)
Number of subjects: 312
Study 36045877 — intervention group
Group type: EXPERIMENTAL
Intervention: Progesterone suppository (800 mg daily; 400 mg twice daily)
Number of subjects: 312
Study 36045877 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal progesterone suppository groups
Number of subjects: 312
Study 36045877 — intervention group
Group type: COMPARATOR
Intervention: IM progesterone groups
Number of subjects: 312
Study 32173113 — intervention group
Group type: EXPERIMENTAL
Intervention: Suprachoroidally injected CLS‐TA
Number of subjects: 160
Study 32173113 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment (control)
Number of subjects: 160
Study 34664221 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 (VD3) 4000 IU daily for 3 months
Number of subjects: 86
Study 34664221 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 86
Study 32770661 — intervention group
Group type: EXPERIMENTAL
Intervention: 75 grams of oral glucose + 6 grams of oral sodium chloride (NaCl) load
Number of subjects: 10
Study 32770661 — intervention group
Group type: COMPARATOR
Intervention: 75 grams of glucose alone
Number of subjects: 10
Study 35916700 — intervention group
Group type: EXPERIMENTAL
Intervention: Full imi intervention web application (treatment)
Number of subjects: 270
Study 35916700 — intervention group
Group type: COMPARATOR
Intervention: Resource page-only version of the imi site (control)
Number of subjects: 270
Study 33772806 — intervention group
Group type: EXPERIMENTAL
Intervention: Approach-positive faces (n = 12)
Number of subjects: 25
Study 33772806 — intervention group
Group type: EXPERIMENTAL
Intervention: Balanced approach of positive and neutral faces (n = 13)
Number of subjects: 25
Study 33772806 — intervention group
Group type: EXPERIMENTAL
Intervention: Both conditions (AAT + BA)
Number of subjects: 25
Study 32731424 — intervention group
Group type: COMPARATOR
Intervention: Only diet suggestions
Number of subjects: 100
Study 32731424 — intervention group
Group type: EXPERIMENTAL
Intervention: Both diet and exercise prescription
Number of subjects: 100
Study 35485687 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral tablets of zinc sulfate twice a day for 3 months
Number of subjects: 80
Study 35485687 — intervention group
Group type: COMPARATOR
Intervention: Control group (no placebo)
Number of subjects: 80
Study 34194139 — intervention group
Group type: EXPERIMENTAL
Intervention: Tension adjustment technique under saddle anesthesia (Group II)
Number of subjects: 80
Study 34194139 — intervention group
Group type: COMPARATOR
Intervention: Tension-free technique (Group I)
Number of subjects: 80
Study 34194139 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 80
Study 35689014 — intervention group
Group type: EXPERIMENTAL
Intervention: Messages optimized for central route processing
Number of subjects: 50
Study 35689014 — intervention group
Group type: COMPARATOR
Intervention: Messages optimized for peripheral route processing
Number of subjects: 50
Study 32902928 — intervention group
Group type: EXPERIMENTAL
Intervention: Gluten ingestion during low FODMAP diet
Number of subjects: 33
Study 32902928 — intervention group
Group type: EXPERIMENTAL
Intervention: Low FODMAP diet
Number of subjects: 33
Study 32902928 — intervention group
Group type: EXPERIMENTAL
Intervention: Habitual gluten-free diet
Number of subjects: 33
Study 32331091 — intervention group
Group type: EXPERIMENTAL
Intervention: Esketamine nasal spray (56-84 mg twice-weekly for 4 weeks) + oral antidepressant (AD)
Number of subjects: 0
Study 32331091 — intervention group
Group type: EXPERIMENTAL
Intervention: Esketamine nasal spray (56-84 mg once-weekly or once-every-other-week) + oral antidepressant (AD)
Number of subjects: 0
Study 34762850 — intervention group
Group type: EXPERIMENTAL
Intervention: IANB
Number of subjects: 96
Study 34762850 — intervention group
Group type: COMPARATOR
Intervention: INF
Number of subjects: 96
Study 34319487 — intervention group
Group type: EXPERIMENTAL
Intervention: Pocket-sized ultrasound devices (PUDs)
Number of subjects: 52
Study 34319487 — intervention group
Group type: COMPARATOR
Intervention: Standard ultrasound devices (SUDs)
Number of subjects: 52
Study 35040102 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment guided by serial ultrasound of the inferior vena cava‐collapsibility index (IVC‐CI) and B‐lines on lung ultrasound (LUS)
Number of subjects: 2040
Study 35040102 — intervention group
Group type: COMPARATOR
Intervention: Standard monitoring
Number of subjects: 2040
Study 33165621 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine (400 mg twice daily for 2 doses, then 200 mg twice daily for 8 doses)
Number of subjects: 479
Study 33165621 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 479
Study 33165621 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine
Number of subjects: 479
Study 35916128 — intervention group
Group type: EXPERIMENTAL
Intervention: Lisinopril (up to 40 mg)
Number of subjects: 141
Study 35916128 — intervention group
Group type: COMPARATOR
Intervention: Candesartan (up to 32 mg)
Number of subjects: 141
Study 32646930 — intervention group
Group type: EXPERIMENTAL
Intervention: Anakinra
Number of subjects: 0
Study 32646930 — intervention group
Group type: EXPERIMENTAL
Intervention: Canakinumab
Number of subjects: 0
Study 32646930 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 33640347 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac Resynchronization Therapy (CRT)
Number of subjects: 406
Study 32887594 — intervention group
Group type: EXPERIMENTAL
Intervention: New model of care for knee osteoarthritis (12-week community based, individualized, multidisciplinary approach)
Number of subjects: 20
Study 32887594 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 20
Study 35522197 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-temperature plasma (LTP)
Number of subjects: 30
Study 35522197 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 30
Study 33502448 — intervention group
Group type: EXPERIMENTAL
Intervention: Machine learning algorithm for surgical predictions
Number of subjects: 683
Study 35918101 — intervention group
Group type: EXPERIMENTAL
Intervention: Positivity-oriented photography intervention
Number of subjects: 109
Study 35918101 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 109
Study 33476542 — intervention group
Group type: EXPERIMENTAL
Intervention: High-calorie group (calorie-enriched formula)
Number of subjects: 100
Study 33476542 — intervention group
Group type: COMPARATOR
Intervention: Conventional group (standard formula)
Number of subjects: 100
Study 32083298 — intervention group
Group type: EXPERIMENTAL
Intervention: Nanocarbon group
Number of subjects: 0
Study 32083298 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 32180248 — intervention group
Group type: EXPERIMENTAL
Intervention: SPOT GRADE intervention (surgical bleeding severity scale)
Number of subjects: 0
Study 32180248 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized sequence of controlled bleeding videos
Number of subjects: 0
Study 32180248 — intervention group
Group type: EXPERIMENTAL
Intervention: Kappa statistic methodology
Number of subjects: 0
Study 35042738 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine treatment for 26 weeks
Number of subjects: 1221
Study 35042738 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment for 26 weeks
Number of subjects: 1221
Study 35042738 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased stroke severity (measured by NIHSS)
Number of subjects: 1221
Study 35042738 — intervention group
Group type: EXPERIMENTAL
Intervention: Past depression
Number of subjects: 1221
Study 35042738 — intervention group
Group type: EXPERIMENTAL
Intervention: Being married or partnered
Number of subjects: 1221
Study 35042738 — intervention group
Group type: EXPERIMENTAL
Intervention: Cultural context (Australia and New Zealand vs Vietnam)
Number of subjects: 1221
Study 33798090 — intervention group
Group type: EXPERIMENTAL
Intervention: Medication-related harm identified through retrospective review of patient records.
Number of subjects: 9076
Study 32643358 — intervention group
Group type: EXPERIMENTAL
Intervention: QLB dexmedetomidine interfascial (QD IF)
Number of subjects: 50
Study 32643358 — intervention group
Group type: COMPARATOR
Intervention: QLB dexmedetomidine intravenous (QD IV)
Number of subjects: 50
Study 35758127 — intervention group
Group type: EXPERIMENTAL
Intervention: FOLFOX plus cetuximab
Number of subjects: 0
Study 35758127 — intervention group
Group type: COMPARATOR
Intervention: FOLFOX alone
Number of subjects: 0
Study 34461255 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness Based Cognitive Therapy (MBCT)
Number of subjects: 84
Study 34461255 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychoeducation
Number of subjects: 84
Study 34461255 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 84
Study 32228330 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-mg fast-release melatonin
Number of subjects: 8
Study 32228330 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 32708428 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrolysed high-protein, lactose-free milkshakes (500 mL, 50 g protein)
Number of subjects: 41